Home › Funds › Empery Asset Management, LP › BCTXL

Empery Asset Management, LP position in BCTXL

BRIACELL THERAPEUTICS CORP · Health Care

Empery Asset Management, LP reported holding 300,000 shares of BCTXL (BRIACELL THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$267K, representing 0.31% of its reported portfolio and ranking #21 among its reported holdings. Empery Asset Management, LP has disclosed BCTXL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)300.00K sh
Reported value held$267.00K
Portfolio Weight0.31%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Empery Asset Management, LP's BCTXL position evolved

Empery Asset Management, LP first disclosed a stake in BCTXL in Q1 2026 at 300,000 shares (US$309K). Across 2 filings, Empery Asset Management, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 300,000 shares valued at US$267K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 300.00K $309.03K New
Q2 2026 300.00K $267.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCTXL and 13F data

BCTXL (BRIACELL THERAPEUTICS CORP) is a Health Care company. 9 other funds we track also report a position in BCTXL — the largest reported positions include SABBY MANAGEMENT, LLC (US$169K), IRIDIAN ASSET MANAGEMENT LLC/CT (US$58K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCTXL

All BCTXL fund holders →

FAQ

How long has Empery Asset Management, LP held BCTXL?

Empery Asset Management, LP has disclosed BCTXL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Empery Asset Management, LP's current position in BCTXL?

As of Q2 2026, Empery Asset Management, LP holds 300.00K shares of BCTXL (BRIACELL THERAPEUTICS CORP), valued at $267.00K, representing 0.31% of its reported portfolio and ranking #21.

Has Empery Asset Management, LP been buying or selling BCTXL?

In the latest 13F filing (Q2 2026), Empery Asset Management, LP held unchanged its position in BCTXL.

Which other funds hold BCTXL?

Other major institutional holders of BCTXL include SABBY MANAGEMENT, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, among 9 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.